Actual developments in European regulatory and health technology assessment of new cancer drugs: What does this mean for oncology in Europe?

L. Bergmann, H. Enzmann, K. Broich, A. Hebborn, S. Marsoni, L. Goh, J. F. Smyth, H. Zwierzina

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numbermdt488
Pages (from-to)303-306
Number of pages4
JournalAnnals of Oncology
Issue number2
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Medicine(all)

Cite this